Rein Therapeutics Announces Preliminary Blinded Phase 2 RENEW Data Showing Encouraging Lung Function Trends in Patients with Idiopathic Pulm
33% of evaluable patients demonstrated improvement over baseline in forced vital capacity (FVC) at W
33% of evaluable patients demonstrated improvement over baseline in forced vital capacity (FVC) at W